IGC Pharma, Inc.IGCNYSE
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank64
3Y CAGR-36.9%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
-36.9%/yr
Annual compound
Percentile
P64
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 7.77% |
| 2024 | 26.22% |
| 2023 | 5.56% |
| 2022 | 30.91% |
| 2021 | -24.47% |
| 2020 | -160.57% |
| 2019 | -72.44% |
| 2018 | -38.82% |
| 2017 | -782.09% |
| 2016 | 93.90% |